Skip to main content
. 2022 Apr 12;9:843952. doi: 10.3389/fcvm.2022.843952

Table 4.

Prevalence of clinical features in the total patient population and patient subgroups.

A. Clinical features LVNC total (n = 100) RV-HT (n = 22) RV-NT (n = 78) RV-HT vs. RV-NT p
Palpitation 20% 23% 19% 0.717
Palpitation with documented arrhythmia 7% 9% 6% 0.663
Palpitation without documented arrhythmia 13% 14% 13% 0.920
Arrhythmia 22% 27% 21% 0.499
Non-sustained ventricular arrhythmia 3% 5% 3% 0.630
Ventricular extrasystoles 15% 14% 15% 0.839
Supraventricular extrasystoles 4% 9% 3% 0.168
Atrioventricular reentry tachycardia 2% 5% 1% 0.334
Bradycardia 1% 5% 0% 0.058
Syncope 8% 14% 6% 0.270
Non-ischemic ECG abnormalities 9% 5% 10% 0.408
Previous thromboembolic event 3% 5% 3% 0.630
Transient ischemic attack 1% 0% 1% 0.594
Stroke 1% 5% 0% 0.058
Pulmonary microembolism 1% 0% 1% 0.594
Sudden cardiac death 1% 0% 1% 0.594
Positive family history 23% 18% 24% 0.543
Positive family history and other clinical features 10% 14% 9% 0.520
Atypical chest pain 11% 9% 12% 0.746
No symptoms or family history 32% 32% 32% 0.983

LVNC, left ventricular non-compaction; RV-HT, patients with right ventricular hypertrabeculation; RV-NT, patients with normal right ventricular trabeculation.